Hepatic ischemia reperfusion injury: Pathogenic mechanisms and basis for hepatoprotection
Open Access
- 14 July 2003
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 18 (8), 891-902
- https://doi.org/10.1046/j.1440-1746.2003.03056.x
Abstract
This review highlights recent advances in our understanding of mechanisms underlying reperfusion injury to the liver after warm hepatic ischemia. Sinusoidal endothelial cells and hepatocytes are targets of injury in the early ‘cytotoxic’ phase, although participation of apoptosis in the cell‐death process remains contentious. Kupffer cells may play an important role as the initial cytotoxic cell type and are likely a source of reactive oxygen species and proinflammatory mediators, particularly tumor necrosis factor (TNF)‐α. The latter are involved with subsequent neutrophil activation and recruitment. Microcirculatory disruption results from an imbalance between the actions of vasoconstrictors and vasodilators, such as nitric oxide, and also has a major impact on reperfusion injury. There is growing evidence that a brief prior ischemia–reperfusion period, termed ‘ischemic preconditioning’, is hepatoprotective. This can be mimicked by drugs that produce oxidative stress, and by interleukin‐6 and TNF‐α; both these cytokines are involved with priming hepatocytes to enter the cell cycle. Several mechanisms have been implicated including mobilization of adenosine and activation of adenosine type 2 receptors, nitric oxide, abrogation of TNF synthesis, preservation of energy metabolism, protection of the microcirculation and accelerated cell‐cycle entry. A better understanding of preconditioning mechanisms will lead to novel approaches to improve outcomes of liver surgery.Keywords
This publication has 103 references indexed in Scilit:
- Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in miceHepatology, 1999
- Hepatic Ischemia/Reperfusion in Rats Induces iNOS Gene Transcription by Activation of NF-κBBiochemical and Biophysical Research Communications, 1999
- Reduced plasma transforming growth factor-β1 levels in patients with chronic hepatitis C after interferon-α therapy: association with regression of hepatic fibrosisJournal of Hepatology, 1999
- Role of Cytokines and Cytokine-Producing Cells in Reperfusion Injury to the LiverSeminars in Liver Disease, 1999
- Hepatic preconditioning in rats is defined by a balance of adenosine and xanthineHepatology, 1998
- Mitochondrial dysfunction and cytoskeletal disruption during chemical hypoxia to cultured rat hepatic sinusoidal endothelial cells: The pH paradox and cytoprotection by glucose, acidotic pH, and glycineHepatology, 1998
- Role of endothelins and nitric oxide in hepatic reperfusion injury in the ratHepatology, 1998
- HYPOXIA, BUT NOT REOXYGENATION, INDUCES INTERLEUKIN 6 GENE EXPRESSION THROUGH NF-??B ACTIVATION1Transplantation, 1997
- Glycine Protects Hepatocytes from Injury Caused by Anoxia, Cold Ischemia and Mitochondrial Inhibitors, But Not Injury Caused by Calcium Ionophores or Oxidative StressHepatology, 1993
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985